Doctors fire him almost two months after he broke his femur during motocross in Ceuti
Pedro Acosta from Mazarrón will make another appearance at the Austrian GP this weekend. This was confirmed on Thursday by the championship organizers via a statement published on the official World Cup website. Mazarrón’s shark, which broke his femur in a fall during a fall while training on the Ceutí motocross circuit, received the green light from the World Cup medical service on Thursday, the same that two weeks ago was not allowed to ride his bike in Silverstone for the rider’s own safety.
Acosta, who still has a noticeable limp, has been training for several weeks and last Saturday, without going further, he drove the Cartagena circuit at 42º. Mounted on an R1, it had a good pace and the sensations were positive. He looked ready to compete in Britain two weeks ago, but Dr. Charte, the championship’s chief of medical services, objected. This time he gave ‘ok’.
However, the discomfort in his left leg persists and the performance the Red Bull KTAM Ajo team rider will deliver this weekend at the Red Bull Ring, the highest elevation track of all World Championships, is unknown. They are at their highest point about 800 meters above sea level and by no means lower than 720. These are huge numbers compared to those of most world circuits.
This used to have little impact on the bikes, other than caring for the engines, but now it’s crucial for aerodynamics.
Acosta, with an incredibly competitive gene, returns to fight with the best riders on the Moto2 grid, despite having an intramedullary nail in his thigh to hold and strengthen the bone, as a result of the accident that he contracted almost two months ago in Ceuti.
Source: La Verdad

I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.